
    
      The duration of the treatment with alendronate is not well established. The investigators
      recruited 228 women with postmenopausal osteoporosis. They all received alendronate during
      the first 3 years of monitoring and were later on randomized to whether different regimens of
      intermittent treatment or to carry on 3 years more.
    
  